Genpact Limited (NYSE:G) has been assigned an average recommendation of “Buy” from the twelve brokerages that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $34.61.
Several research analysts have weighed in on the company. Zacks Investment Research downgraded Genpact from a “hold” rating to a “sell” rating in a report on Thursday, February 15th. JPMorgan Chase & Co. dropped their price objective on Genpact from $38.00 to $37.00 and set a “neutral” rating for the company in a report on Wednesday, February 14th. Citigroup dropped their price objective on Genpact from $39.00 to $37.50 and set a “buy” rating for the company in a report on Tuesday, February 13th. BMO Capital Markets upped their price objective on Genpact to $35.00 and gave the stock a “market perform” rating in a report on Tuesday, February 13th. Finally, Cantor Fitzgerald restated a “buy” rating and set a $36.00 price objective on shares of Genpact in a report on Tuesday, February 13th.
Shares of Genpact (NYSE:G) traded up $0.09 during trading on Friday, hitting $31.55. The company had a trading volume of 686,509 shares, compared to its average volume of 849,156. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.65 and a quick ratio of 1.65. Genpact has a 1 year low of $23.34 and a 1 year high of $34.79. The firm has a market cap of $6,027.72, a P/E ratio of 23.54, a P/E/G ratio of 2.01 and a beta of 0.57.
Genpact (NYSE:G) last issued its quarterly earnings results on Monday, February 12th. The business services provider reported $0.43 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.41 by $0.02. The company had revenue of $734.41 million during the quarter, compared to the consensus estimate of $723.55 million. Genpact had a return on equity of 23.53% and a net margin of 9.61%. Genpact’s revenue was up 7.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.43 EPS. equities research analysts expect that Genpact will post 1.55 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 21st. Shareholders of record on Friday, March 9th will be given a $0.075 dividend. This is a boost from Genpact’s previous quarterly dividend of $0.06. This represents a $0.30 dividend on an annualized basis and a yield of 0.95%. The ex-dividend date of this dividend is Thursday, March 8th. Genpact’s dividend payout ratio is presently 17.91%.
In other Genpact news, SVP Arvinder Singh sold 22,855 shares of the company’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $32.23, for a total value of $736,616.65. Following the completion of the transaction, the senior vice president now directly owns 37,623 shares of the company’s stock, valued at approximately $1,212,589.29. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Piyush Mehta sold 12,500 shares of the company’s stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $32.00, for a total transaction of $400,000.00. Following the completion of the transaction, the senior vice president now directly owns 77,944 shares of the company’s stock, valued at $2,494,208. The disclosure for this sale can be found here. Over the last three months, insiders sold 164,934 shares of company stock valued at $5,346,881. 1.41% of the stock is currently owned by corporate insiders.
Institutional investors have recently modified their holdings of the company. American International Group Inc. acquired a new stake in shares of Genpact in the 4th quarter valued at about $114,000. Meeder Asset Management Inc. acquired a new stake in shares of Genpact in the 3rd quarter valued at about $128,000. Advisor Group Inc. raised its stake in shares of Genpact by 59.8% in the 3rd quarter. Advisor Group Inc. now owns 5,017 shares of the business services provider’s stock valued at $145,000 after purchasing an additional 1,878 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in shares of Genpact by 7.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 6,508 shares of the business services provider’s stock valued at $181,000 after purchasing an additional 455 shares in the last quarter. Finally, Verition Fund Management LLC acquired a new stake in shares of Genpact in the 2nd quarter valued at about $210,000. Institutional investors and hedge funds own 94.18% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/02/22/genpact-limited-g-receives-average-recommendation-of-buy-from-analysts.html.
Genpact Company Profile
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.